Brett Bird
Gerontology · Victorville, CANPI 1780453191
Payments from drug & device makers
Across 61 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$294
- Pfizer$242
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$173
- Lilly USA, LLC$84
- Dexcom, Inc.$79
- Xeris Pharmaceuticals, Inc.$78
- plus $422 from 14 others
What the payments were for
- Food & beverage$1,372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $294 |
| Pfizer | 8 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $173 |
| Lilly USA, LLC | 4 | $84 |
| Dexcom, Inc. | 4 | $79 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Boehringer Ingelheim | 3 | $56 |
| Merck | 2 | $52 |
| Mylan Specialty L.p. | 2 | $41 |
| Astellas Pharma US Inc | 1 | $33 |
| AstraZeneca | 2 | $32 |
| Vertex | 1 | $32 |
| Amgen | 2 | $31 |
| Corcept Therapeutics | 1 | $29 |
| GSK | 1 | $26 |
| Krystal Biotech Inc | 1 | $23 |
| AbbVie | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
- Wegovy$122
How this compares
$1,372 in reported general payments places this provider in the 75th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 48 | $44,885 |
| WegovySemaglutide | 20 | $26,391 |
| JardianceEmpagliflozin | 16 | $21,381 |
| FarxigaDapagliflozin Propanediol | 15 | $12,781 |
| EliquisApixaban | 12 | $11,010 |
| BreynaBudesonide/Formoterol Fumarate | 12 | $2,902 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 73 | $2,552 |
| Sertraline Hcl | 25 | $2,537 |
| Gabapentin | 53 | $690 |
| Diclofenac Sodium | 16 | $514 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $499 |
| Lidocaine | 11 | $497 |
| Hydroxyzine Hcl | 23 | $463 |
| Atorvastatin Calcium | 66 | $412 |
| Levothyroxine Sodium | 39 | $390 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $294 | $71,27668 claims |
| Boehringer IngelheimJardiance | $56 | $21,38116 claims |
| AstraZenecaFarxiga | $32 | $12,78115 claims |
| PfizerEliquis | $242 | $11,01012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 348 gerontology providers in California.
Other gerontology in Victorville
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.